Research reading room
The Metastatic Prostate Cancer Project (Provisional, June 2021)
Summary
The Metastatic Prostate Cancer Project (Provisional, June 2021) is a study catalogued by cBioPortal DataHub under the cancer-type code prostate. EvidenceHelix groups it with prostate studies.
Study description
The Metastatic Prostate Cancer Project is a patient-driven initiative. This study includes genomic data, cfDNA tumor fractions, patient-reported data (pre-pended as PRD), medical record data (MedR), and pathology report data (PATH). As these data were generated in a research, not a clinical, laboratory, they are for research purposes only and cannot be used to inform clinical decision-making. All annotations have been de-identified. More information is available at www.mpcproject.org. For questions about these data, including how to cite, please visit www.mpcproject.org/data-release or direct questions to data@mpcproject.org.
Text as published in the source's study metadata.
Citation & PubMed
The source lists no citation or PubMed id for this study.
Source & licence
Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.
Source metadata
- Study identifier
- mpcproject_broad_2021
- Short name
- The MPC Project.
- Source cancer-type code
- prostate
- Reference genome
- not given
- Source access groups
- not given
- Original study
- View on cBioPortal
- Metadata file
- meta_study.txt at e1b75cd25b
- Database licence
- ODC Open Database License (ODbL) 1.0
Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.
Citations
The source lists no citation or PubMed id for this study.
Related studies
-
Prostate Cancer (DKFZ, Cancer Cell 2018)
Whole genome and transcriptome sequencing of tumor/normal pairs from 292 prostate cancer patients.
ProstateOther published and consortium studiesSource code prostatePubMed 1 -
Prostate Cancer Brain Metastases (Bern, Nat Commun. 2022)
Prostate Cancer Brain Metastases, Switzerland. Dataset was generated in 2019 by Antonio Rodriguez, John Gallon, Salvatore Piscuoglio and Mark Rubin.
ProstateOther published and consortium studiesSource code prostatePubMed 1 -
Prostate Cancer MDA PCa PDX (MD Anderson, Clin Cancer Res 2024)
Targeted sequencing and whole-genome sequencing of 88 MD Anderson Prostate Cancer PDX models derived from 38 patients with tumor.
ProstateOther published and consortium studiesSource code prostatePubMed 1 -
Prostate Cancer (MSK, Cell Metab 2020)
MSK-IMPACT Sequencing of 18 prostate cancer tumor/normal pairs.
ProstateMSK studiesSource code prostatePubMed 1 -
Prostate Cancer (MSK, Clin Cancer Res 2024)
Targeted sequencing of 2,257 prostate cancer patient samples and their matched normals via MSK-IMPACT platform. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licen…
ProstateMSK studiesSource code prostatePubMed 1 -
Metastatic Prostate Adenocarcinoma (MCTP, Nature 2012)
Exome sequencing of 61 prostate cancer tumor/normal pairs (50 metastatic CRPCs and 11 high-grade localized prostate cancers). Generated by Arul Chinnaiyan's and Scott Tomlins' labs at the University of Michigan.
ProstateOther published and consortium studiesSource code pradPubMed 1 -
Metastatic Prostate Adenocarcinoma (SU2C/PCF Dream Team, PNAS 2019)
Whole exome sequencing of 444 castrate resistant prostate cancer tumor/normal pairs. SU2C-PCF Dream Team: Precision Therapy for Advanced Prostate Cancer.
ProstateOther published and consortium studiesSource code pradPubMed 1 -
Metastatic Prostate Cancer (SU2C/PCF Dream Team, Cell 2015)
Whole-exome sequencing of 150 metastatic prostate cancer tumor/normal pairs by the SU2C/PCF Dream Team.
ProstateOther published and consortium studiesSource code pradPubMed 1